Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risperidone for Attention‐deficit Hyperactivity Disorder in People With Intellectual Disabilities Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities_Edited__no_change_to_conclusions_. Accessed 05 June 2023.
Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities_Edited__no_change_to_conclusions_. Accessed June 5, 2023.
Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities_Edited__no_change_to_conclusions_
Risperidone for Attention‐deficit Hyperactivity Disorder in People With Intellectual Disabilities Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities Edited (no change to conclusions)
ID - 432949
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -